Table Table 2.
Clinicopathological features | Frequency (%) | Receptor 5‐HT2A | P value | |
---|---|---|---|---|
Mean ± SD/number of patients | ||||
Overexpression | ||||
− | + | |||
Age (year) | 0.101 | |||
<53 | 15 (45.5) | 13 | 2 | |
≥53 | 18 (54.5) | 11 | 7 | |
Sex | 0.191 | |||
Male | 29 (87.9) | 20 | 9 | |
Female | 4 (12.1) | 4 | 0 | |
Non‐tumorous liver histology | 0.031 ∗ | |||
Non‐cirrhotic | 2 (6.1) | 0 | 2 | |
Chronic hepatitis | 16 (48.5) | 11 | 5 | |
Cirrhotic | 15 (45.5) | 13 | 2 | |
Tumour size (cm) a | 0.202 | |||
<5 | 9 (27.3) | 8 | 1 | |
≥5 | 24 (72.7) | 16 | 8 | |
Tumour recurrence | 0.825 | |||
Absence | 12 (36.4) | 9 | 3 | |
Presence | 21 (63.6) | 15 | 6 | |
Venous infiltration b | 0.475 | |||
Absence | 15 (45.5) | 10 | 5 | |
Presence | 18 (54.5) | 14 | 4 | |
Number of tumour nodules | 0.097 | |||
1 | 25 (75.8) | 20 | 5 | |
≥2 | 8 (24.2) | 4 | 4 | |
Cellular differentiation c,d | 0.524 | |||
Well differentiated | 11 (33.3) | 9 | 2 | |
Moderately differentiated | 14 (42.4) | 10 | 4 | |
Poorly differentiated | 7 (21.2) | 4 | 3 | |
AJCC stage | 0.392 | |||
I and II | 15 (45.5) | 12 | 3 | |
III and IV | 18 (54.5) | 12 | 6 |
*P < 0.05.
Tumour size was defined as the length of the largest tumour nodule.
Venous infiltration was defined based on findings by microscopic and major pathologic examination.
Well differentiated (Edmonson grade 0–2); moderately differentiated (Edmonson grade 3); poorly differentiated (Edmonson grade 4).
Partial data is not available and statistics were based on available data of 32 patients.